AU2011201422B2 — Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Assigned to Besins Healthcare Luxembourg SARL · Expires 2012-02-09 · 14y expired
What this patent protects
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In 5 one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Met…
USPTO Abstract
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In 5 one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided. GM2612962_1 1100 U er Lini f Normal Range -- -- -- ----------------- --- - -- -- -- -- - a 800 E 300 --- - - - - - - - - - - - - - - - - - - - - - - L- erL- i of N-rnaIRang E5 00 --- - - - - - - - - - - - - - - - - - - - - - Low er Linit of Norm l FRane M 200 72 76 80 84 88 92 96 100 104 108 112 116 120 124 128 132 136 140 144 Time (hr)
Drugs covered by this patent
- Aveed (TESTOSTERONE UNDECANOATE) · Marius
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.